Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» drug pricing
drug pricing
Biopharma ramps up lobbying spend as drug pricing legislation nears
Biopharma ramps up lobbying spend as drug pricing legislation nears
Endpoints
drug pricing
lobbying
legislation
GSK
Teva Pharmaceutical
Merck
JNJ
Flag link:
New Kaiser analysis shows how limiting price negotiations to targeted drugs may better focus upcoming legislation
New Kaiser analysis shows how limiting price negotiations to targeted drugs may better focus upcoming legislation
Endpoints
drug pricing
Flag link:
3 changes coming to drug pricing
3 changes coming to drug pricing
MedCity News
drug pricing
regulatory
Flag link:
CBO Report Shows Enacting Drug Pricing Legislation Will Result In Fewer New Drugs
CBO Report Shows Enacting Drug Pricing Legislation Will Result In Fewer New Drugs
Forbes
legislation
CBO
drug pricing
R&D
Flag link:
Life sciences pumping more cash than ever into R&D, but drug pricing limits could stymie that tide: report
Life sciences pumping more cash than ever into R&D, but drug pricing limits could stymie that tide: report
Fierce Pharma
drug pricing
R&D
Flag link:
Bills, Bills, Bills: Congress Advances Bills to Address Drug Competition
Bills, Bills, Bills: Congress Advances Bills to Address Drug Competition
FDA Law Blog
competition
FDA
drug pricing
legislation
Flag link:
How Biden’s infrastructure plan will go after biopharma companies beyond drug pricing
How Biden’s infrastructure plan will go after biopharma companies beyond drug pricing
Endpoints
Joe Biden
White House
legislation
tax inversions
drug pricing
taxes
tax havens
Flag link:
Lawmakers are once again eyeing drug prices—and this time, the threat to pharma is real: analysts
Lawmakers are once again eyeing drug prices—and this time, the threat to pharma is real: analysts
Fierce Pharma
Joe Biden
drug pricing
Flag link:
‘A mess across the board’: Senate committee kicks off talks on drug pricing reforms
‘A mess across the board’: Senate committee kicks off talks on drug pricing reforms
Endpoints
drug pricing
Sentate
Flag link:
Rising costs force 39% of Americans to skip, ration meds, survey says
Rising costs force 39% of Americans to skip, ration meds, survey says
Beckers Hospital Review
drug pricing
Flag link:
The top drugs that could be impacted by an obscure provision in the pandemic relief law
The top drugs that could be impacted by an obscure provision in the pandemic relief law
BioPharma Dive
Medicaid
drug rebates
pandemic
stimulus
legislation
drug pricing
Flag link:
Countering payers, drugmakers say net prices declined in 2020
Countering payers, drugmakers say net prices declined in 2020
BioPharma Dive
drug pricing
payers
Flag link:
Several states are proposing laws to cut drug prices
Several states are proposing laws to cut drug prices
Beckers Hospital Review
drug pricing
legislation
Flag link:
As COVID-19 becomes a business, vaccine makers confront thorny pricing questions
As COVID-19 becomes a business, vaccine makers confront thorny pricing questions
BioPharma Dive
COVID-19
vaccines
pandemic
drug pricing
Flag link:
Could a Senate drug pricing bill be 'a positive' for pharma? One analyst says so
Could a Senate drug pricing bill be 'a positive' for pharma? One analyst says so
Fierce Pharma
drug pricing
legislative
Senate
Flag link:
Most Favored Nation Drug Pricing Rule on Hold Awaiting Changes
Most Favored Nation Drug Pricing Rule on Hold Awaiting Changes
FDA Law Blog
drug pricing
Medicare Part B
most favored nation
Flag link:
Drug price hikes without new evidence upped spending by $1.2B, ICER says
Drug price hikes without new evidence upped spending by $1.2B, ICER says
MedCity News
drug pricing
ICER
Flag link:
Perspective: Drug price transparency in the Biden era
Perspective: Drug price transparency in the Biden era
RAPS.org
drug pricing
transparency
Joe Biden
Flag link:
Insulin’s Out-Of-Pocket Cost Burden To Diabetic Patients Continues To Rise Despite Reduced Net Costs To PBMs
Insulin’s Out-Of-Pocket Cost Burden To Diabetic Patients Continues To Rise Despite Reduced Net Costs To PBMs
Forbes
diabetes
insulin
drug pricing
Flag link:
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 with nearly 600 price hikes
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 with nearly 600 price hikes
Fierce Pharma
drug pricing
Pfizer
AbbVie
Teva Pharmaceutical
Sanofi
Gilead Sciences
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »